Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
1,424,543
-
Share change
-
-3,424,007
-
Total reported value
-
$4,012,037
-
Put/Call ratio
-
118%
-
Price per share
-
$2.81
-
Number of holders
-
28
-
Value change
-
-$9,548,927
-
Number of buys
-
7
-
Number of sells
-
14
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2021
As of 30 Jun 2021,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,424,543 shares.
The largest 10 holders included
Parkman Healthcare Partners LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, LPL Financial LLC, CITADEL ADVISORS LLC, Intellectus Partners, LLC, Game Plan Financial Advisors, LLC, ACT Capital Management, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and Cutter & CO Brokerage, Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.